Improvement of chronic congestive heart-failure by oral captopril

Details

Serval ID
serval:BIB_25F71F2ED1CA
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Improvement of chronic congestive heart-failure by oral captopril
Journal
Lancet
Author(s)
Turini  G. A., Brunner  H. R., Gribic M., Waeber B., Gavras H.
ISSN
0140-6736
Publication state
Published
Issued date
1979
Peer-reviewed
Oui
Volume
1
Number
8128
Pages
1213-5
Language
english
Notes
Journal Article
Abstract
Catopril, an inhibitor of angiotensin converting enzyme, was given orally during cardiac catheterisation to 6 normotensive patients with refractory congestive heart-failure. 60--180 minutes after administration of 25 mg captopril, arterial pressure fell by 25%, cardiac index rose by 38%, and left-ventricular pressure and right-atrial pressure fell by 25% and 40% respectively. Plasma-renin activity rose while plasma noradrenaline and aldosterone fell. These data suggest that, in the short term, captopril can reduce both preload and afterload, and improve cardiac function, in refractory congestive heart-failure.
Keywords
Administration, OralAdultAldosterone Antagonists*Angiotensin-Converting Enzyme InhibitorsBlood Pressure/drug effectsCardiac Output/drug effectsChronic DiseaseDrug EvaluationHeart Failure/*drug therapy/physiopathologyHumansMaleMiddle AgedNorepinephrine/antagonists & inhibitorsProline/administration & dosage/*analogs & derivativesRenin/bloodVascular Resistance/drug effects
Pubmed
Web of science
Create date
04/03/2009 16:04
Last modification date
20/08/2019 14:04
Usage data